4043.0 Global Pharmaceutical issues

Tuesday, November 9, 2010: 8:30 AM - 10:00 AM
: Five public health experts from Canada and the U.S. will contribute to this panel discussion. These professionals will present on issues related to the current state of global pharmaceuticals and issues around access, safety and regulation, including: • The framework and original intentions of Canada's Assess to Medicines Regime (CAMR). The impact of CAMR as compared with its intentions. • The origin of ingredients used in medicines in the U.S. pharmaceutical supply chain. Jurisdiction concepts for regulating medications both domestically and internationally and the role of other regulating agencies such as WHO-IMPACT and NAFDAC. The FDA’s previous role in drug safety monitoring and the expanded regulatory role as indicated in the 2007 FDA Amendments Law. • The current realities of global health partnerships working in emergency response to deliver health product donations. Factors associated with the use of medicines and material aid distribution. The benefits, barriers and strategies of global health partnerships operating in emergency response. • Strategies for strengthened the international health supply system by combining medical, logistic and service statistics data. Methods to monitor and evaluate medical supply needs and usage. Approaches to improving knowledge up and down the supply chains. • Limitations of current approach to measuring disparities in the use of pharmaceuticals in the U.S. The underlying factors associated with the use of medicines and disparities in their use from a societal perspective. The advantages of using population-based pharmaceutical data.
Session Objectives: Discuss US and international pharmaceutical regulatory systems and how their design and/or implementation ensures or undermines drug safety and access to pharmaceuticals in both developed and developing nations. Describe the design and use of current pharmaceutical monitoring and evaluation systems with a focus on access and use in both developing world settings and US domestic settings. Analyze the impact of global health partnerships in disaster response and identify strategies through which aid efforts could better enhance the capacity of beneficiary communities.
Maggie Huff-Rousselle, PhD, MBA, MA
Maggie Huff-Rousselle, PhD, MBA, MA

Canada's Access to Medicines Regime: Social Justice Attempted & Subsequent Failure?
Jillian Kohler, PhD, Joel Lexchin, MD, Victoria Kuek, LLM and James Orbinski, MD, MA
Can the FDA be an International Police Force?
R. Cherie Robertson, PharmD, Jessica Charles, MPH and Maggie HuffRousselle, PhD, MBA, MA

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: International Health
Endorsed by: Trade and Health Forum

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)

See more of: International Health